(Q47808734)

5 February 2018

title

Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's disease. (English)

1 reference

5 February 2018

0 references

0 references

8

Soininen H

1 reference

5 February 2018

Pirttilä T

1

1 reference

5 February 2018

Koivisto K

2

1 reference

5 February 2018

Mehta PD

3

1 reference

5 February 2018

Reinikainen K

4

1 reference

5 February 2018

Kim KS

5

1 reference

5 February 2018

Kilkku O

6

1 reference

5 February 2018

Heinonen E

7

1 reference

5 February 2018

Riekkinen P Sr

9

1 reference

5 February 2018

Wisniewski HM

10

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

5 February 2018

published in

Neuroscience Letters

1 reference

5 February 2018

volume

249

1 reference

5 February 2018

page(s)

21-24

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

Altered apolipoprotein E secretion in cytokine treated human astrocyte cultures.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900381-4

7 January 2021

10.1016/S0304-3940(98)00381-4

Identifiers

DOI

1 reference

5 February 2018

release_ad36rxecynfn7kopzc7wsjr6om

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ad36rxecynfn7kopzc7wsjr6om

24 November 2022

mapped directly with Wikidata item

PubMed ID

9672379

1 reference

5 February 2018